Clinical trials
Phase 1/2 Endometrial Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 5 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Genmab | 2 |
| Seagen Inc. | 2 |
| Artios Pharma Ltd | 1 |
| BioNTech SE | 1 |
| Cancer Research UK | 1 |
| Eisai Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Imperial College London | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 19 |
| Ovarian Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Uterine Cervical Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Colorectal Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.